Company page

Seres Therapeutics, Inc.

Seres Therapeutics, Inc. (ticker: MCRB) is a public company based in the United States with a market capitalization of approximately $64 million. The company focuses on developing innovative therapies to treat various diseases by harnessing the power of the microbiome. Their research aims to improve patient outcomes through advanced microbiome-based treatments.